TY - JOUR
T1 - Risk of hypertension among first-time symptomatic kidney stone formers
AU - Kittanamongkolchai, Wonngarm
AU - Mara, Kristin C.
AU - Mehta, Ramila A.
AU - Vaughan, Lisa E.
AU - Denic, Aleksandar
AU - Knoedler, John J.
AU - Enders, Felicity T.
AU - Lieske, John C.
AU - Rule, Andrew D.
N1 - Funding Information:
This project was supported by National Institute of Diabetes and Digestive and Kidney Diseases Mayo Clinic O’Brien Urology Research Center grants DK100227 and DK83007 and Center for Translational Science Activities grant UL1 TR000135 from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health (NIH), and made possible by Rochester Epidemiology Project AG034676 from the NIH, US Public Health Service. Preliminary results of this work were presented at the Scientific Meeting of the American Society of Hypertension held May 13–17, 2016 in New York, New York. The funding sources had no role in the study design, conduct, or reporting. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.
Publisher Copyright:
© 2017 by the American Society of Nephrology.
PY - 2017
Y1 - 2017
N2 - Background and objectives Prior work has suggested a higher risk of hypertension in kidney stone formers but lacked disease validation and adjustment for potential confounders. Certain types of stone formers may also be at higher risk of hypertension. Design, setting, participants, & measurements In our study, incident symptomatic stone formers in Olmsted County from 2000 to 2011 were manually validated by chart review and age and sex matched to Olmsted County controls. We followed up patients through November 20, 2015. Hypertension was also validated by manual chart review, and the risk of hypertension in stone formers compared with controls was assessed both univariately and after adjusting for comorbidities. The risk of hypertension among different subtypes of stone formers was also evaluated. Results Among 3023 coded stone formers from 2000 to 2011, a total of 1515 were validated and matched to 1515 controls (mean age was 45 years old, and 56% were men). After excluding those with baseline hypertension (20% of stone formers and 18% of controls), 154 stone formers and 110 controls developed hypertension. Median follow-up time was 7.8 years in stone formers and 9.6 years in controls. Stone formers were found to have a higher risk of hypertension compared with controls (hazard ratio, 1.50; 95% confidence interval, 1.18 to 1.92), even after adjusting for age, sex, body mass index, serum creatinine, CKD, diabetes, gout, coronary artery disease, dyslipidemia, tobacco use, and alcohol abuse (hazard ratio, 1.58; 95% confidence interval, 1.12 to 2.21). Results were similar after excluding patients who were ever on a thiazide diuretic (hazard ratio, 1.65; 95% confidence interval, 1.16 to 2.38). Stone composition, radiographic stone burden, number of subsequent stone events, and stone removal surgeries were not associated with hypertension (P.0.05 for all). Conclusions The risk of hypertension was higher after the first symptomatic kidney stone event. However, kidney stone severity, type, and treatment did not associate with hypertension.
AB - Background and objectives Prior work has suggested a higher risk of hypertension in kidney stone formers but lacked disease validation and adjustment for potential confounders. Certain types of stone formers may also be at higher risk of hypertension. Design, setting, participants, & measurements In our study, incident symptomatic stone formers in Olmsted County from 2000 to 2011 were manually validated by chart review and age and sex matched to Olmsted County controls. We followed up patients through November 20, 2015. Hypertension was also validated by manual chart review, and the risk of hypertension in stone formers compared with controls was assessed both univariately and after adjusting for comorbidities. The risk of hypertension among different subtypes of stone formers was also evaluated. Results Among 3023 coded stone formers from 2000 to 2011, a total of 1515 were validated and matched to 1515 controls (mean age was 45 years old, and 56% were men). After excluding those with baseline hypertension (20% of stone formers and 18% of controls), 154 stone formers and 110 controls developed hypertension. Median follow-up time was 7.8 years in stone formers and 9.6 years in controls. Stone formers were found to have a higher risk of hypertension compared with controls (hazard ratio, 1.50; 95% confidence interval, 1.18 to 1.92), even after adjusting for age, sex, body mass index, serum creatinine, CKD, diabetes, gout, coronary artery disease, dyslipidemia, tobacco use, and alcohol abuse (hazard ratio, 1.58; 95% confidence interval, 1.12 to 2.21). Results were similar after excluding patients who were ever on a thiazide diuretic (hazard ratio, 1.65; 95% confidence interval, 1.16 to 2.38). Stone composition, radiographic stone burden, number of subsequent stone events, and stone removal surgeries were not associated with hypertension (P.0.05 for all). Conclusions The risk of hypertension was higher after the first symptomatic kidney stone event. However, kidney stone severity, type, and treatment did not associate with hypertension.
KW - Alcoholism
KW - Body Mass Index
KW - Chronic
KW - Chronic kidney disease
KW - Comorbidity
KW - Coronary artery disease
KW - Creatinine
KW - Diabetes mellitus
KW - Dyslipidemias
KW - Epidemiology
KW - Follow-Up Studies
KW - Gout
KW - Humans
KW - Hypertension
KW - Kidney Calculi
KW - Kidney stones
KW - Male
KW - Renal Insufficiency
KW - Sodium Chloride Symporter Inhibitors
KW - Thiazide diuretics
KW - Tobacco Use
UR - http://www.scopus.com/inward/record.url?scp=85021770634&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85021770634&partnerID=8YFLogxK
U2 - 10.2215/CJN.06600616
DO - 10.2215/CJN.06600616
M3 - Article
C2 - 28148559
AN - SCOPUS:85021770634
SN - 1555-9041
VL - 12
SP - 476
EP - 482
JO - Clinical Journal of the American Society of Nephrology
JF - Clinical Journal of the American Society of Nephrology
IS - 3
ER -